Invention Grant
US07897175B2 Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor
有权
包含CETP抑制剂和HMG-CoA还原酶抑制剂的剂型
- Patent Title: Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor
- Patent Title (中): 包含CETP抑制剂和HMG-CoA还原酶抑制剂的剂型
-
Application No.: US10739567Application Date: 2003-12-18
-
Publication No.: US07897175B2Publication Date: 2011-03-01
- Inventor: Dwayne T. Friesen , David K. Lyon , Douglas A. Lorenz , Bruno C. Hancock , Timothy J. McDermott , Ravi M. Shanker
- Applicant: Dwayne T. Friesen , David K. Lyon , Douglas A. Lorenz , Bruno C. Hancock , Timothy J. McDermott , Ravi M. Shanker
- Applicant Address: US OR Bend
- Assignee: Bend Research, Inc.
- Current Assignee: Bend Research, Inc.
- Current Assignee Address: US OR Bend
- Agency: Chernoff, Vilhauer, McClung & Stenzel
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/20 ; A61K9/48
Abstract:
A dosage form comprises (1) a solid amorphous dispersion comprising a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer and (2) an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosage form.
Public/Granted literature
- US20040197398A1 Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor Public/Granted day:2004-10-07
Information query
